{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-24-000039","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.379864+00:00","generated_at":"2026-06-04T03:18:33.591878+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Pulmonx appoints Mehul Joshi as CFO effective April 3, 2024","bullets":["Mehul Joshi named CFO; previously CFO of PhenomeX and senior finance roles at ResMed and Gilead.","Annual base salary $450K; target bonus 50% of base; sign-on bonus $200K with clawback provisions.","Initial equity grants: non-statutory stock option valued at $1.375M and RSU valued at $1.35M, both vesting over 4 years.","John McKune, interim CFO since Oct 2023, returns to VP Finance and Corporate Controller.","Severance and change-in-control benefits: 12 months salary plus bonus acceleration upon qualifying termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-24-000039","json":"https://secwatch.observer/filing/0001127537-24-000039.json","markdown":"https://secwatch.observer/filing/0001127537-24-000039.md","text":"https://secwatch.observer/filing/0001127537-24-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/0001127537-24-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/lung-20240402.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:18:33.591878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e0b7f25f5b","claim":"Mehul Joshi was appointed as Chief Financial Officer and Principal Financial and Accounting Officer at Pulmonx Corp.","evidence_excerpt":"On March 19, 2024, the board of directors of Pulmonx Corporation (the “Company”) appointed Mehul Joshi as the Company’s Chief Financial Officer and Principal Financial and Accounting Officer, effective upon commencement of his employment with the Company on April 3, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/0001127537-24-000039-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Principal Financial and Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}